New Enzyme Study may be effective in reducing muscle spasticity

                                                                  

A new study shows that an enzyme called hyaluronidase may be effective in reducing muscle spasticity resulting from neurological disorders such as multiple sclerosis.

The results were published in a study titled “Human Recombinant Hyaluronidase Injections For Upper Limb Muscle Stiffness in Individuals With Cerebral Injury: A Case Series,” in the journal EBioMedicine by a group of researchers from the NYU Langone Medical Center.

Muscle spasticity is a condition characterized by muscle stiffness in one or more muscles and reduced joint movement, which causes pain and disability. This condition is associated with neurological damage caused by disorders that affect the connections between neurons that control muscle movement (motor neurons) and muscles, such as multiple sclerosis, stroke, traumatic brain injury, cerebral palsy, or spinal cord injury.

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews